Based at the University of Surrey’s Clinical Research Building, the HTA draws on the research, clinical, commercial and business accelerator expertise of its founding partners to improve health and well-being for citizens, address system challenges and support the productivity of SMEs to drive economic growth.
The new website outlines the range of facilities available via the HTA, as well as detailing its offer to key audiences of health tech innovators, the health and care system, academia and citizens.
Commenting on the new site, Prof Helen Rostill, Senior Responsible Officer for the HTA, said that www.surreyhearlandshta.uk was a great showcase for the work taking place.
“The HTA is working on clinical and care priorities that are really important to the people who live in Surrey and our surrounding areas,” she said.
“All of this is possible thanks to the funding from the Enterprise EM3 LEP, which helped us to develop this unique space and intellectual environment.
“The HTA has the dual purpose of stimulating economic growth while increasing health outcomes for the region. This is a truly exciting initiative that will see clinical health and care staff working alongside researchers, technology innovators and local population to co-produce innovations that meet our citizens’, and the region’s, needs.”
The HTA is already working on a range of projects that look at areas including the remote monitoring of mental health services, app-based support for patients with Type 1 Diabetes, and the impact of nocturnal disturbance and their impacts on sleep and health in care homes. Many of its projects will connect with and capitalise on the rich health research environment that already exists at the University of Surrey.